Results 111 to 120 of about 24,454 (211)
[What is the value of determining immunoreactive GHRH in acromegaly?]
, 1999 Acromegaly is usually due to autonomous, excessive secretion of growth hormone from a pituitary adenoma. One would expect growth hormone-releasing factor (GHRH) in these patients to be suppressed.
Bürgi, U +3 more
core
Changes in retinal microvasculature and serum Gremlin-1 levels in acromegaly: A case-control study
Photodiagnosis and Photodynamic TherapyObjective: There are controversial results about the effects of GH/IGF-1 on retinal vasculature. Gremlin-1 has roles in both pituitary tumorigenesis and angiogenesis.
Gokcen Unal Kocabas +10 more
doaj +1 more source
Acromegaly - Pathology, diagnosis and treatment
, 2005 This book reviews the pathophysiology and physical manifestations of acromegaly and discusses the multiple treatment options now available for the management of the patient with acromegaly.
Lamberts, S. W. +4 more
core +1 more source
Extraocular Muscle Enlargement in Acromegaly
, 2022 Acromegaly is a disorder resulting from the hypersecretion of growth hormone (GH), usually by a pituitary adenoma. Ophthalmic manifestations can include visual field defects, cranial nerve palsies, and extraocular muscle (EOM) enlargement.
Alaa Bou Ghannam; Dalia El Hadi; Hala Mostafa; Hana Mansour; Ibrahim Hashim; Soubhi Tahhan; Tharwat Al Zahran
core
BiomedicinesIntroduction. Acromegaly is an endocrine pathology characterized by the overproduction of human growth hormone. The present study aimed to analyze three-dimensional speckle-tracking echocardiography (3DSTE)-derived tricuspid annular (TA) properties in ...
Attila Nemes +6 more
doaj +1 more source
, 2017 The aim of the present study was to evaluate the serial changes of GH and IGF-1 in seven patients with naive, active acromegaly following presurgical treatment of the somatostatin analog pasireotide long-acting release (LAR) and octreotide LAR.
Chang, Jan-Shun;Tseng, Ham-Min;Chang, Tien-Chun +1 more
core +1 more source
, 2019 In patients with acromegaly, chronic GH and IGF-I excess commonly causes a specific cardiomyopathy characterized by a concentric cardiac hypertrophy associated with diastolic dysfunction and, in later stages, with systolic dysfunction ending in heart ...
Colao A. +3 more
core +1 more source
Cardiovascular complications in acromegaly
, 2004 Cardiovascular morbidity and mortality are increased in acromegaly. In fact, GH and IGF-I excess induces a specific cardiomyopathy. The early stage of acromegaly is characterized by the hyperkinetic syndrome (high heart rate and increased systolic output)
R. Pivonello +6 more
core +1 more source
Anxiety, depression and acromegaly: a systematic review
Purpose: scientific literature highlights risk factors linked to the onset of psychopathology in different medical pathological contexts. Acromegaly is a rare condition, particularly noteworthy due to the associated clinical psychological features.
Schwarz, Peter +8 more
core +1 more source